Literature DB >> 22336804

Chinese medicinal herbs for acute bronchitis.

Lanhui Jiang1, Ka Li, Taixiang Wu.   

Abstract

BACKGROUND: Acute bronchitis is one of the most common diagnoses made by primary care physicians. It is traditionally treated with antibiotics (although the evidence for their effectiveness is weak, and modest at best) and other even less effective treatments. Chinese medicinal herbs have also been used as a treatment.
OBJECTIVES: This review aimed to summarise the existing evidence on the comparative effectiveness and safety of Chinese medicinal herbs for treating uncomplicated acute bronchitis. SEARCH
METHODS: We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library 2011, Issue 4) which includes the Cochrane Acute Respiratory Infections Group's Specialised Register, MEDLINE (1966 to 19 September 19, 2011), EMBASE (1988 to 19 September 2011) and CNKI and the Chinese Biomedical Database (CBM) (1980 to 19 September, 2011). SELECTION CRITERIA: Randomised controlled trials (RCTs) comparing Chinese medicinal herbs with placebo, antibiotics or other Western medicines for the treatment of uncomplicated acute bronchitis. DATA COLLECTION AND ANALYSIS: At least two review authors independently extracted data and assessed trial quality. MAIN
RESULTS: In this updated review, 74 studies involving 6877 participants were reported as RCTs by the study authors. None of them met the inclusion criteria for this review. Out of the 74 trials, we identified 39 as non-RCTs and 35 compared different Chinese herbal medicines in the intervention and control groups. AUTHORS'
CONCLUSIONS: There is insufficient quality data to recommend the routine use of Chinese herbs for acute bronchitis. Trial design limitations of the individual studies meant that we could not draw any conclusions about the benefits of Chinese herbs for acute bronchitis. In addition, the safety of Chinese herbs is unknown due to the lack of toxicological evidence for these herbs, although adverse events were reported in some case reports.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22336804      PMCID: PMC7202254          DOI: 10.1002/14651858.CD004560.pub4

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  15 in total

Review 1.  Chinese medicinal herbs for acute bronchitis.

Authors:  T Wu; X Chen; X Duan; N Juan; G Liu; J Qiao; Q Wang; J Wei; J Zhen; L Zhou
Journal:  Cochrane Database Syst Rev       Date:  2005-07-20

2.  Content of family practice. Part I. Rank order of diagnoses by frequency. Part II. Diagnoses by disease category and age/sex distribution.

Authors:  D W Marsland; M Wood; F Mayo
Journal:  J Fam Pract       Date:  1976-02       Impact factor: 0.493

3.  Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma.

Authors:  D L Hahn; R W Dodge; R Golubjatnikov
Journal:  JAMA       Date:  1991-07-10       Impact factor: 56.272

4.  Mycoplasma pneumoniae and adenovirus respiratory illnesses in military and university personnel, 1959-1966.

Authors:  W J Mogabgab
Journal:  Am Rev Respir Dis       Date:  1968-03

5.  Diagnosis of acute bronchitis in adults: a national survey of family physicians.

Authors:  K C Oeffinger; L M Snell; B M Foster; K G Panico; R K Archer
Journal:  J Fam Pract       Date:  1997-11       Impact factor: 0.493

6.  The management of acute bronchitis in general practice: results from the Australian Morbidity and Treatment Survey, 1990-1991.

Authors:  R A Meza; C Bridges-Webb; G P Sayer; D A Miles; V Traynor; S Neary
Journal:  Aust Fam Physician       Date:  1994-08

7.  National Hospital Ambulatory Medical Care Survey: 1998 outpatient department summary.

Authors:  A L Slusarcick; L F McCaig
Journal:  Adv Data       Date:  2000-07-27

8.  Chlamydia pneumoniae (TWAR): a common agent in acute bronchitis.

Authors:  G Falck; L Heyman; J Gnarpe; H Gnarpe
Journal:  Scand J Infect Dis       Date:  1994

9.  Bronchitis, pneumonitis and pneumonia in University of Wisconsin students.

Authors:  A S EVANS; M BROBST
Journal:  N Engl J Med       Date:  1961-08-31       Impact factor: 91.245

10.  Clinical features and treatment of acute bronchitis.

Authors:  J Dunlay; R Reinhardt
Journal:  J Fam Pract       Date:  1984-05       Impact factor: 0.493

View more
  8 in total

Review 1.  Oral Astragalus (Huang qi) for preventing frequent episodes of acute respiratory tract infection in children.

Authors:  Guobin Su; Xiankun Chen; Zhuangzhu Liu; Lihong Yang; Cecilia Stålsby Lundborg; Zehuai Wen; Xinfeng Guo; Xindong Qin; Jueyao Liang; Xusheng Liu
Journal:  Cochrane Database Syst Rev       Date:  2016-12-01

Review 2.  Complementary and alternative medicine for the treatment of bronchiolitis in infants: A systematic review.

Authors:  Kok Pim Kua; Shaun Wen Huey Lee
Journal:  PLoS One       Date:  2017-02-17       Impact factor: 3.240

3.  Effectiveness of antitussives, anticholinergics or honey versus usual care in adults with uncomplicated acute bronchitis: a study protocol of an open randomised clinical trial in primary care.

Authors:  Josep M Cots; Ana Moragas; Ana García-Sangenís; Rosa Morros; Ainhoa Gomez-Lumbreras; Dan Ouchi; Ramon Monfà; Helena Pera; Jesus Pujol; Carolina Bayona; Mariam de la Poza-Abad; Carl Llor
Journal:  BMJ Open       Date:  2019-05-16       Impact factor: 2.692

Review 4.  The Contribution of Complementary and Alternative Medicine to Reduce Antibiotic Use: A Narrative Review of Health Concepts, Prevention, and Treatment Strategies.

Authors:  Erik W Baars; Eefje Belt-van Zoen; Thomas Breitkreuz; David Martin; Harald Matthes; Tido von Schoen-Angerer; Georg Soldner; Jan Vagedes; Herman van Wietmarschen; Olga Patijn; Merlin Willcox; Paschen von Flotow; Michael Teut; Klaus von Ammon; Madan Thangavelu; Ursula Wolf; Josef Hummelsberger; Ton Nicolai; Philippe Hartemann; Henrik Szőke; Michael McIntyre; Esther T van der Werf; Roman Huber
Journal:  Evid Based Complement Alternat Med       Date:  2019-02-03       Impact factor: 2.629

5.  Efficacy and safety of Tanreqing oral liquid in treatment of acute bronchitis: study protocol for a randomized controlled trial.

Authors:  Guilan Cheng; Bin She; Bing Mao; Hongli Jiang
Journal:  Trials       Date:  2022-05-07       Impact factor: 2.728

6.  Efficacy and safety of GHX02 in the treatment of acute bronchitis: protocol of a phase II, double-blind, randomised placebo-controlled trial.

Authors:  Yee Ran Lyu; Won-Kyung Yang; So Jung Park; Seung-Hyeong Kim; Wee-Chang Kang; In Chul Jung; Yang Chun Park
Journal:  BMJ Open       Date:  2018-05-14       Impact factor: 2.692

7.  Healthcare utilisation for eating disorders among patients with depression: a cross-sectional study in Taiwan.

Authors:  Chiu-Lan Yan; Li-Ting Kao; Ming-Kung Yeh; Wu-Chien Chien; Chin-Bin Yeh
Journal:  BMJ Open       Date:  2019-12-29       Impact factor: 2.692

8.  Efficacy and Safety of GHX02 in the Treatment of Acute Bronchitis and Acute Exacerbation of Chronic Bronchitis: A Phase Ⅱ, Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial.

Authors:  Su Won Lee; Yee Ran Lyu; Si Yeon Kim; Won Kyung Yang; Seung Hyung Kim; Ki Mo Kim; Sung-Wook Chae; Weechang Kang; In Chul Jung; Yang Chun Park
Journal:  Front Pharmacol       Date:  2022-01-17       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.